Language
Skip Navigation

CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAM

PLEASE NOTE: All providers and pharmacies that prescribe or dispense clozapine must re-certify in the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program by November 15, 2021. Prescribers and pharmacies that fail to re-certify cannot prescribe or dispense clozapine. To avoid disruption in care, prescribers must also re-enroll their patients in the Clozapine REMS program by November 15, 2021.To view the full memorandum, click here.

last updated: October 22, 2021

Ready to Join Us?

Talk To Us About Questions Or Concerns

Monday–Friday | 9 a.m.–5 p.m. (ET)

Already A Member?

Talk To Us About Any Questions or Concerns

Monday–Friday | 9 a.m.–5 p.m. (ET)

Speak To Someone In Your Community

Find Someone In Your Neighborhood And In Your Language